Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Ortivus will now deliver MobiMed to Estonia’s entire ambulance fleet!

Ortivus
Download the release

We are very pleased to announce that the Estonian Health Insurance Fund Haigekassa has decided to award Telia Eesti, with Ortivus as a subcontractor, a contract on the delivery of MobiMed ePR to Estonia’s entire ambulance fleet. Estonia is a new customer for Ortivus and an important milestone for Ortivus’ further growth in Europe. The order value is estimated to 26 MSEK and the contract duration is 5 years with a possible extension of another 5 years. The extension has an additional order value of estimated 26 MSEK.

Estonia is situated in the north of Europe and covers an area of 45 300 square kilometers. There are currently 10 bodies of emergency medical care that operate ambulance crews in in the country and around 100 emergency vehicles covering a population of 1.3M. With this award from Eesti Haigekassa, Ortivus will be delivering MobiMed ePR, electronic patient record, to all emergency vehicles across Estonia’s prehospital care. The order value for Ortivus includes yearly license fees, service & support and adaption and integration of MobiMed for the Estonian market.
 
“Estonia is known for being at the forefront of e-health and we are very pleased to have received this award. We look forward to delivering a state-of-the-art prehospital ePR solution to Estonia, to further enhance efficiency and safety of the prehospital care in the country.” – Says Elias Obaid, European Sales Manager at Ortivus.
 
In relation to the offering to the Estonian market, Ortivus joined forces with the local partner Telia Eesti As. Telia will be signing contract with Eesti Haigekassa and Ortivus will act as a subcontractor. Ortivus will provide the customer with a SaaS (Software as a Service) solution including MobiMed ePR on iOS and integrations to national systems. Telia will provide hardware and first line support in Estonian. Second line support will be provided by Ortivus.
 
This award is an important milestone for Ortivus’ further international expansion and proof that Ortivus’ competitive solutions meet the requirements of a broad range of customers, from small organisations to large, national solutions.
 
“The medical sector is currently one of the fastest digitalizing areas and we are pleased that, together with Ortivus, we can contribute in making the Estonian ambulance work even more efficient by providing modern ICT solutions,” – Says Kristjan Kukk, Head of key- and large corporate customers department at Telia Eesti.
 
This award decision does not mean that a contract has been signed and that contractual obligations applies. The contract can be signed at any point after the award decision has been announced. The process of finalizing the contract has started.
 
About Telia Eesti AS
Telia Eesti is the market leader in the ICT sector in Estonia, offering the broadest range of communication, home entertainment, cyber security and IT services. Telia has the technological competence, unique knowledge of the customer, and investment capacity to fulfill the vision of a new generation ICT service provider.
 
Telia invests approximately 50 million euros in the Estonian market every year and this makes Telia one of the largest investors on the local market. Telia Eesti contributes to the development of society through environmental protection, digital inclusion, privacy, and cyber security.

Contacts


For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus


Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient
healthcare. The company was founded in 1985 and is today a leading provider of mobile digital
solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise
in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.

MobiMed is a modular platform that currently is used by over 12,000 paramedics in over 2,700 emergency vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'
vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists
of an electronic patient record for decision support, collection of patient data and clinical documentation.
MobiMed has a total weight of 3.5kg and is created to function in a demanding environment and out in
the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-12-15 13:20 CET.

Attachments


Ortivus will now deliver MobiMed to Estonia’s entire ambulance fleet!

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.